Neuroblastoma in a 55-year-old patient: a case report

Case Rep Oncol. 2010 Sep;3(3):458-62. doi: 10.1159/000322863. Epub 2010 Dec 4.


Background: Neuroblastomas account for 97% of all neuroblastic tumors and for approximately 15% of all pediatric cancer fatalities. However, in adults neuroblastoma is a very rare finding.

Case report: Here, we present the case of a 55-year-old patient who was diagnosed with neuroblastoma stage IV one year after the false diagnosis of a non-secretory multiple myeloma.

Results: The patient received six cycles of a chemotherapy protocol with cisplatin, etoposide and vindesine alternating with vincristine, dacarbazine, ifosfamide and doxorubicin, but the response to treatment was insufficient (stable disease).

Conclusion: The standard chemotherapy protocols used for children are not sufficient for adult patients. Different treatment approaches are needed to improve the prognosis of adult patients with neuroblastoma.

Keywords: Chemotherapy; Multiple myeloma; Neuroblastoma; Response to treatment.

Publication types

  • Case Reports